Ono Pharmaceutical Co., Ltd.

OPHLF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$152$17,673-$6,545$14,951
Dep. & Amort.$63$9,238$8,728$9,170
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$84$799$16,583-$1,502
Other Non-Cash$47-$27,687$20,230-$13,879
Operating Cash Flow$346$3,373$38,996$8,740
Investing Activities
PP&E Inv.-$13-$2,250-$1,421-$1,204
Net Acquisitions$0$0$0$0
Inv. Purchases-$9$0$0$0
Inv. Sales/Matur.$32$0$0$0
Other Inv. Act.-$2$1,951$16,747$10,023
Investing Cash Flow$8-$299$15,326$8,819
Financing Activities
Debt Repay.-$51-$8,354-$8,306$0
Stock Issued$0$0$0$0
Stock Repurch.-$0$0$0$0
Dividends Paid-$9-$17,396-$992-$17,770
Other Fin. Act.-$6$25,571$0-$8,320
Financing Cash Flow-$66-$179-$9,298-$26,090
Forex Effect-$22$55-$1,442$2,424
Net Chg. in Cash$266$138,991$43,585$160,982
Supplemental Information
Beg. Cash$964$0$160,982$0
End Cash$1,231$138,991$204,567$160,982
Free Cash Flow$335$1,123$37,575$7,536
Ono Pharmaceutical Co., Ltd. (OPHLF) Financial Statements & Key Stats | AlphaPilot